defer us trials until cashflow, page-22

"I can't afford to increase my holdings, given the losses I have had to endure to date."

With all due respect to your personal circumstances Resourced, I don't think this is a valid reason for not pursuing a capital raising or for deferring upcoming US trials for Vitrogro.

Regardless of the recent setback for CE mark, provided that any proposed CR is equitable to existing retail investors then I don't have a problem with management raising more money for US trails and working capital so long as it is used wisely and spent efficiently.